Sex Hormone-Binding Globulin Reflects Hormone Transport, Bioavailability & Metabolic-Hormonal Balance

What is SHBG?

Sex Hormone-Binding Globulin (SHBG) is a protein produced primarily by the liver that binds to sex hormones in circulation, particularly testosterone, dihydrotestosterone (DHT), and estradiol. Its primary role is to regulate how much of these hormones remain “free” and biologically active versus bound and unavailable to tissues. Only unbound (free) hormones can readily enter cells and activate hormone receptors. Because of this, SHBG plays a major role in determining androgen and estrogen activity throughout the body. Even when total hormone levels appear normal, abnormal SHBG levels can significantly alter hormone bioavailability and contribute to symptoms of hormonal imbalance. SHBG production is influenced by numerous physiological factors, including insulin levels, liver function, thyroid status, inflammation, body composition, age, and overall metabolic health.

Why Test for Progesterone?

Evaluating SHBG levels helps clinicians better understand hormone availability and investigate symptoms related to androgen or estrogen imbalance, such as:

• Fatigue, low libido, or reduced exercise recovery

• Erectile dysfunction or reduced sexual function

• Hair loss, acne, or androgen excess symptoms

• Irregular menstrual cycles or infertility

• PMOS and insulin resistance

• Obesity or metabolic syndrome

• Thyroid dysfunction

• Monitoring hormone replacement therapy or testosterone therapy

SHBG is particularly valuable because total testosterone alone may not accurately reflect hormone activity. Two individuals with identical testosterone levels can have very different free testosterone levels depending on SHBG concentration.

Clinical Significance of SHBG Levels:

High SHBG Levels :

SHBG levels above ~70–80 nmol/L may occur with hyperthyroidism, liver disease, aging, calorie restriction, low insulin states, oral estrogen therapy, or reduced androgen production. Elevated SHBG reduces free testosterone availability even when total testosterone appears normal. Clinically, high SHBG is often associated with fatigue, low libido, reduced muscle mass, poor exercise recovery, erectile dysfunction, menstrual irregularities, or symptoms of androgen deficiency.

Low SHBG Levels:

SHBG levels below ~20 nmol/L are commonly associated with insulin resistance, obesity, metabolic syndrome, hypothyroidism, fatty liver disease, chronic inflammation, or elevated androgen states. Lower SHBG increases the amount of free testosterone and free estradiol circulating in the body. Clinically, low SHBG may contribute to acne, androgenic hair loss, PCOS-related symptoms, irritability, and metabolic dysfunction. Persistently low SHBG is also considered an early marker of cardiometabolic risk and impaired insulin sensitivity.

Actionable Insights:

SHBG should always be interpreted alongside total testosterone, free testosterone, estradiol, albumin, thyroid markers, and metabolic markers such as fasting insulin and HbA1c. Abnormal SHBG often reflects broader metabolic or endocrine dysfunction rather than a primary disease process itself. Elevated SHBG may artificially lower free hormone availability, while suppressed SHBG can amplify androgen e ects despite “normal” total hormone levels. Insulin resistance is one of the most common drivers of low SHBG, making SHBG a useful indirect marker of metabolic health. Liver function, thyroid status, inflammation, nutritional status, medications, and hormone therapies can all significantly alter SHBG production. Monitoring trends over time may provide better clinical insight than isolated measurements.

Optimal Ranges

• Men: ~20–50 nmol/L

• Women (Premenopausal): ~40–120 nmol/L

• Women (Postmenopausal): Often lower than premenopausal ranges